维普中文期刊产品整合服务
26篇 您的检索式:作者名="APA R"
    题名 作者 年代 出处 被引量
1Pituitary adenylate cyclase-activating polypeptide modulates plasminogen activator expression in rat granulosa cell显示文摘Apa R Lanzone A Miceli F 2002Biol Reprod2002,66,3:1
2Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma?显示文摘Belosi C Selvaggi L Apa R 2006Hum Reprod2006,21,12:1
3Pituitary adenylate cyclase-activating polypeptide modulates plasminogen activator expression in rat granulosa cell显示文摘Apa R Lanzone A Miceli F 2002Biology of reproduction2002,66,3:1
4Recombinant versus urinary follicle-stimulating hormone in the low-dose regimen in anovulatory patients with polycystic ovary syndrome: a safer and more effective treatment显示文摘Fulghesu AM Apa R Belosi C 2001HormRes2001,55,5:1
5The relationship between leptin levels and chronic complication in patients with type 2 diabetes mellitus显示文摘SARI R BALCI M K APA YDIN C 2010Metab Syndr Relat Disord2010,8,6:1
6Recombinant versus urinary follicle-stimulating hormone in the low-dose regimen in anovulatory patients with polycystic ovary syndrome: a safer and more effective treatment显示文摘Fulghesu AM Apa R Belosi C 2001Horm Res2001,55,5:1
7The moderating effect of exploita- tive and exploratory learning on internationalization per- formance relationship in SMEs 显示文摘Noni I D and Apa R 2015Journal of Interna- tional Entrepreneurship2015,13,2:1
8The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2 7-fold increased risk of polycystic ovary syndrome in a Sardinian population显示文摘Capalbo A Sagnella F Apa R 2012Clin EndocrinoI (Oxf)2012,77,:1
9Recombinant versus urinary follicle-stimulating in the low-dose regimen in anovulatory patients with polycystic ovarian syndrome:a safer and more effective treatment显示文摘Fulghesu A Apa R Belosi C 2001Horm Res2001,55,5:1
10Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it includeultrasound examination of the ovarian stroma? 显示文摘BELOSI C SELVAGGI L APA R 2006Hum Relarod2006,21,8:1
11Recombinant versusurinary follicle-stimulating hormone in the low-dose regi-men in anovulatory patients with polycystic ovary syn-drome:a safer and more effective treatment显示文摘Fulghesu AM Apa R Belosi C 2001HormRes2001,55,5:1
12De novo induced mutations in the deoxycytidine kinase (dCK) gene in rat leukemic clonal cell lines confer resistance to cytarabine (ara-C) and 5-aza-2'-deoxycytidine(DAC)显示文摘Stegmann APA Honders MW Willemze R 1995Leukemia1995,9,:1
13Recombinant versus urinary follicle-stimulating hormone in the low-dose regimen in anovulatory patients with polycystic ovary syndrome:asafer and more effective treatment 显示文摘Fulghesu AM Apa R Belosi C 2001Horm Res2001,55,:1
14The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene(LHCGR)confers up to 2·7-fold increased risk of polycystic ovary syndrome in a Sardinian population显示文摘Capalbo A Sagnella F Apa R 2012Clin Endocrinol2012,77,1:1
15Probiotic administration effect on fecal mutagenieity and micro- flora in the goat's gut显示文摘APAS A L DUPRAZ J ROSS R 2010J Biosci Bioeng2010,110,5:1
16De novo induced mutations in the deoxycytidine kinase(dCK) gene in rat leukemic clonal cell lines confer resistance to cytarabine(Ara-C)and 5-aza2'-deoxycytidine(DAC)显示文摘 Honders MW Willemze R 1995Leukemia1995,9,:1
17Recombinant versus urinary follicle-stimulating hormone in the low-dose regimen in an ovulatory patients with polycystic ovary syndrome: a safe and more effective treatment显示文摘FULGHESU A M APA R BELOSI C 2001Horm Res2001,55,5:1
18Recombinant versusurinary follicle-stimulating hormone in the low-dose regi- men in anovulatory patients with polycystie ovary syn- drome: a safer and more effective treatment显示文摘Fulghesu AM Apa R Belosi C 2001Horm Res2001,55,5:1
19CD4 + CD28 null T lymphocytes are expanded in young women with polyeystic ovary syndrome 显示文摘Niccoli G Apa R Lanzone A 2011Fertil Steri12011,95,8:1
20Clopidogrel pharmacogenetics and it sclinical implications 显示文摘Singh M Th apa B Arora R 2010American Journal of Therapeutics2010,17,3:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费